Sleep pattern changes across the life span from infancy to old age and may additionally be modulated by sex, race/ethnicity, and mental or physical health conditions ([@bibr45-1557988317735412]). Experimental sleep deprivation protocols conducted in healthy young adults led to profound functional changes in cognition and behavior ([@bibr26-1557988317735412]). Sleep deprivation is a changeable behavior and its consequences increase stress levels and accelerate biological aging ([@bibr12-1557988317735412]). Human behavior including stress, physical activity, alcohol consumption, obesity, and sleep deprivation may influence serum testosterone (T) levels ([@bibr4-1557988317735412]). T is a sex steroid hormone that affects primarily male reproductive activities and has anabolic effects on muscle mass formation ([@bibr47-1557988317735412]). T is involved in the sleep--wake cycle and may modulate individual susceptibility to subjective symptoms of sleep deprivation. Low T may affect overall sleep quality and this is particularly proved by the decline in T levels among individuals with sleep deprivation. The paradox is that large doses of exogenous T are associated with abnormalities of sleep duration ([@bibr14-1557988317735412]). Salivary testosterone (sT) ([@bibr13-1557988317735412]; [@bibr15-1557988317735412]) was measured in many previous studies to predict cardiovascular disease (CVD) correlations ([@bibr43-1557988317735412]) as well as mental health ([@bibr16-1557988317735412]). It was concluded that circulatory androgen levels were affected by time and duration of sleep ([@bibr5-1557988317735412]). Although the majority of authors have confirmed an inverse correlation between sleep deprivation and T ([@bibr2-1557988317735412]; [@bibr6-1557988317735412]; [@bibr23-1557988317735412]; [@bibr38-1557988317735412]; [@bibr39-1557988317735412]), the variability of T levels in different age groups remains poorly understood ([@bibr34-1557988317735412]; [@bibr41-1557988317735412]; [@bibr51-1557988317735412]). Elevated T levels were reported in young men during partial sleep deprivation, after exercise ([@bibr1-1557988317735412]). Another study ([@bibr55-1557988317735412]) identified that less T was secreted by middle-aged men at night compared to healthy young men. The effect of sleep deprivation on T levels may be age dependent ([@bibr40-1557988317735412]; [@bibr46-1557988317735412]) rather than independent. Accordingly, large individual differences based on age ([@bibr6-1557988317735412]) may reflect the variability in morning T levels ([@bibr46-1557988317735412]). Changes of some CVD- and depression-associated predictors in sleep deprivation, such as lipid profile and serotonin, have been given more attention in recent studies ([@bibr22-1557988317735412]; [@bibr29-1557988317735412]). Lipid profile changes are viewed as early potential predictors for stepwise progression of pathogenesis of atherosclerosis ([@bibr32-1557988317735412]; [@bibr59-1557988317735412]). Serum serotonin predicts mood changes and psychiatric disorders including depression ([@bibr17-1557988317735412]). Association studies of sleep deprivation with lipid profile or serum serotonin were conducted in human and animal models ([@bibr22-1557988317735412]; [@bibr29-1557988317735412]).

Using saliva as a biological fluid for analysis of steroid hormones, particularly androgen, in sports medicine, psychology, and stress research is increasing ([@bibr25-1557988317735412]). The main reason for this vast use is the current development in enzyme-linked immunoassays, which leads to simplicity, high sensitivity and low cross-reactivity, as well as reliability ([@bibr3-1557988317735412]). sT levels represent the biologically active hormone and correlate with total blood T in healthy and clinical populations ([@bibr3-1557988317735412]; [@bibr25-1557988317735412]; [@bibr53-1557988317735412]).

The aim of the current study was to clarify the effect of sleep deprivation on sT by detecting some of the implemented potential predictors in young Arab men.

Materials and Methods {#section1-1557988317735412}
=====================

Study Design and Participants {#section2-1557988317735412}
-----------------------------

The present work is a prospective cohort study carried out at the Applied Science Private University (ASU) in Amman, Jordan, during the period from January to April 2014. The protocol of this study was based on a chronic model of sleep deprivation ([@bibr52-1557988317735412]) according to participants' sleep behavior during the 3 months prior to the day of the study. To avoid some anticipated variations in the study sample, only Jordanian students who live in Amman city participated in the study. The participants filled out a questionnaire including anthropometric, clinical parameters, and sleep duration patterns. Healthy male nursing students in the age range of 18 to 26 years were invited to participate in this study and their samples were taken for analysis.

Healthy adults typically require 6 to 10 hr of sleep in a 24-hr day. The average need of sleep for healthy adults is around 8 hr daily ([@bibr7-1557988317735412]). Adults who get less than 5 hr of sleep will demonstrate a decline in peak alertness and for that reason are considered sleep deprived ([@bibr9-1557988317735412]). Based on this sleep duration pattern, which was confirmed through interviewing the participants and their roommates, participants were categorized into two groups, a sleep-deprived group (SD) and a non-sleep-deprived group (NSD; [Figure 1](#fig1-1557988317735412){ref-type="fig"}).

![Schematic diagram of study design\
*Note.* SD = sleep-deprived group; NSD = non-sleep deprived group; N = sample size.](10.1177_1557988317735412-fig1){#fig1-1557988317735412}

Informed Consent and Health Screening {#section3-1557988317735412}
-------------------------------------

This study was performed using a protocol for the protection of human subjects approved by the ASU ethical committee under reference DRGS-2013/2014-8. Approval for all the conducted studies was obtained from ASU's ethics committee. All participants were provided with an information sheet, which contained details of the experimental protocol. Participants fully understood the purpose of the study as well as the risks involved. Participants were informed of being free to withdraw from the investigation at any stage. All participants provided written consent prior to the commencement of the study and were asked to complete a health screen questionnaire prior to their participation in the investigation. To avoid confounding factors known to affect leptin and sT levels, participants with diagnosed chronic diseases such as CVDs, diabetes, hepatic, renal, or endocrine disorders and those who had been taking any kind of medication for the past two months prior to the study were excluded.

Salivary Testosterone {#section4-1557988317735412}
---------------------

sT has been widely used as an indicator of the activity of the hypothalamic-pituitary-gonadal axis activity ([@bibr18-1557988317735412]; [@bibr33-1557988317735412]; [@bibr50-1557988317735412]). sT was collected from the participants between 8 and 9 in the morning. To collect salivary samples, participants were provided with a *Salivette^®^* sampling device (cotton) along with both verbal and written instructions for usage. The instructions stated that participants were to collect saliva themselves. Participants were asked to drool passively through a straw into a tube, which was then kept on ice to precipitate mucins and then centrifuged (10,000 × g, 15 min, 4°C). The supernatant (1 mL) was collected and stored at -20ºC until assayed 2 weeks later. sT samples were measured using an enzyme-linked immunosorbent assay (ELISA, SLV-3013, DRG^®^ International, Inc., NJ, USA) at Ibn Al-Haytham Hospital laboratories in Amman, Jordan. The range of the assay is between 1.9 and 5,000 pmol/L and the limits of detection of this assay is 1.9 pmol/L at a 95% confidence limit and the normal range for sT is between 21.2 and 801.2 pmol/L.

Serum Glucose and Lipid Profile {#section5-1557988317735412}
-------------------------------

Fasting venous blood samples were obtained, centrifuged, and stored at -20°C until being assayed. Fasting blood glucose samples were collected at 8 a.m. Blood glucose was confirmed by using *One Touch®* test strips (LifeScan; Johnson & Johnson, Palmitas, CA, USA). Triglycerides, total cholesterol, and high-density lipoprotein cholesterol (HDL-C) were determined using enzymatic colorimetric kits (Linear Chemicals, Barcelona, Spain). Low-density lipoprotein cholesterol (LDL-C) was calculated from the equation recorded in a previous study ([@bibr20-1557988317735412]).

Serum Leptin and Serotonin {#section6-1557988317735412}
--------------------------

Fasting serum leptin and serotonin samples were liquated and stored in polypropylene vials at -20°C until being analyzed 2 weeks later at Al-Khalidi Hospital and Medical Centre Laboratories in Amman, Jordan. Commercial serotonin enzyme immunoassay (EIA) kits were obtained for quantitative determination of serum serotonin (Labor Diagnostika Nord GmbH & Co, KG, Nordhorn, Germany). Analytical sensitivity, as reported by the manufacturer, was 5 ng/mL. Leptin samples were assayed with an EIA kit (DRG Diagnostics, Marburg, Germany) with analytical sensitivity of about 1.0 ng/mL, according to the manufacturer.

Body Mass Index {#section7-1557988317735412}
---------------

On the evaluation day, height (cm) and weight (kg) of participants were recorded. Then, body mass index (BMI, kg/m^2^) was calculated accordingly.

Statistical Analysis {#section8-1557988317735412}
--------------------

Statistical analysis was performed using a statistical software package SPSS, version 19.0 for Windows (Chicago, IL, USA). *T*-test statistical analysis was used to compare the differences of demographic and clinical findings between the means of the two studied groups. The Pearson analysis was used to find if there was any correlation between the participants' characteristics and serum leptin levels. Stepwise multiple regressions and univariate analysis were used to evaluate the effects of independent variables (IDVs), serum lipid profile, BMI, and serotonin, on sT levels as a dependent variable (DV) in SD and NSD groups.

Results {#section9-1557988317735412}
=======

Study Design and Participants {#section10-1557988317735412}
-----------------------------

One hundred and twenty-two healthy male nursing students in the age range of 18 to 26 years were invited to participate in this study. Samples were taken from only 84 participants who committed to follow the study protocol as presented in [Figure 1](#fig1-1557988317735412){ref-type="fig"}. Seven samples were excluded due to insufficient quantity of saliva. Participants were categorized into two groups, a SD group (*n* = 36, 45.4%) and a NSD group (*n* = 41, 54.6%).

Descriptive Characteristics {#section11-1557988317735412}
---------------------------

As reported in [Table 1](#table1-1557988317735412){ref-type="table"}, *t*-test was used to study the difference in all variables between the SD and NSD groups. No significant differences were noted between the SD and NSD groups for all variables. However, the comparison identified higher levels of sT in the SD group (274.7 ± 164.8) compared with NSD group (235.8 ± 131.5) without significant difference in the mean (*p* \> .05). The mean age for SD participants was 22.38 (±1.9) years, whereas it was 21.6 (±1.5) years for NSD participants. Values for mean BMI were higher in the NSD group compared with SD group (26.16 ±4.4 vs. 25.16 ± 4.5). The mean obesity marker, serum leptin, was higher in the NSD group (11.38 ± 9.9) versus (9.4 *±* 8.7) in the SD group. These results may predict the effect of obesity on BMI differences in the two study groups.

###### 

Characteristics of the Two Study Groups Subdivided by Their Sleep Deprivation (Mean ± Standard Deviation).

![](10.1177_1557988317735412-table1)

  Variable                    SD       NSD     *p* value            
  --------------------------- -------- ------- ----------- -------- ------
  Age (years)                 22.39    1.93    21.60       1.49     .251
  sT (pmol/L)                 274.7    164.8   235.8       131.48   .254
  FBG (mg/dL)                 86.68    8.96    86.92       7.43     .872
  Body weight (kg)            77.50    14.61   80.96       15.38    .243
  BMI (kg/m^2^)               25.16    4.45    26.16       4.43     .253
  Leptin (ng/mL)              9.43     8.87    11.38       9.92     .270
  TG (mg/dL)                  123.6    52.8    134.68      58.73    .321
  Total cholesterol (mg/dL)   176.05   34.05   176.87      32.71    .902
  HDL-C (mg/dL)               50.11    8.66    51.25       8.14     .506
  LDL-C (mg/dL)               105.94   35.38   100.29      29.27    .387
  Serum serotonin (ng/mL)     241.14   94.96   268.22      97.73    .142

*Note.* BMI = body mass index; FBG = fasting blood glucose; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; NSD = non-sleep-deprived; SD = sleep-deprived; sT = salivary testosterone; TG = triglycerides.

The Univariate Analysis {#section12-1557988317735412}
-----------------------

Univariate analysis was used to study the association between all variables and sT. As reported in [Tables 2](#table2-1557988317735412){ref-type="table"} and [3](#table3-1557988317735412){ref-type="table"}, there were no significant univariate associations between any of the study variables and sT in both the SD and NSD groups.

###### 

The Univariate Association Between Factors and salivary testosterone in the Sleep-Deprived Group Using Simple Liner Regression.

![](10.1177_1557988317735412-table2)

  Univariate effects estimates                       Coefficients                                                
  -------------------------------------------------- -------------- --------- ---------- --------- ------ ------ ------
  Serum serotonin (ng/mL)                            36             0.431     −0.115     0.976     .269   .073   .118
  Salivary morning cortisol (nmol/L)                 36             6.831     −6.092     19.754    .200   .040   .288
  Salivary night cortisol (nmol/L)                   36             15.216    −3.475     33.908    .306   .94    .106
  Salivary morning dehydroepiandrosterone (nmol/L)   36             0.922     −2.907     4.750     .095   .009   .625
  Salivary night dehydroepiandrosterone (nmol/L)     36             0.020     −0.134     0.174     .051   .003   .791
  FBG (mg/dL)                                        36             −1.012    −8.094     6.070     .050   .002   .773
  Leptin (ng/mL)                                     36             3.145     −4.757     11.048    .140   .019   .424
  Vitamin B12 (pg/mL)                                36             −0.259    −0.795     0.276     .173   .030   .331
  Folic acid (ng/mL)                                 36             −6.032    −22.333    10.269    .132   .017   .457
  TG (mg/dL)                                         36             0.064     −0.875     1.002     .025   .001   .891
  Total cholesterol (mg/dL)                          36             −0.374    −2.312     1.563     .072   .005   .696
  HDL-C (mg/dL)                                      36             5.415     −3.219     14.049    .236   .056   .209
  LDL-C (mg/dL)                                      36             −0.493    −2.357     1.371     .098   .010   .593
  BMI (kg/m^2^)                                      36             42.135    −31.392    115.662   .196   .038   .252
  Body weight (kg)                                   36             1.793     −2.196     5.783     .165   .027   .366
  Height (cm)                                        36             −3.409    −13.293    4.476     .128   .016   .487
  WBC (10^9^/L)                                      36             13.849    −24.616    52.315    .138   .019   .467
  RBC (×10^12^/L)                                    36             −55.003   −128.579   18.573    .300   .090   .136
  Hemoglobin (g/dL)                                  36             3.951     −39.056    46.958    .032   .001   .853
  PCV (%)                                            36             0.266     −11.729    12.260    .008   .000   .964
  MCV (fL)                                           36             2.446     −7.636     12.528    .084   .007   .625
  MCH (pg)                                           36             12.407    −3.773     28.587    .307   .094   .127
  MCHC (g/dL)                                        36             11.575    −9.734     32.883    .223   .050   .273
  Lymphocytes number (×10^9^/L)                      36             −0.352    −12.531    11.828    .012   .000   .953
  Monocytes (%)                                      36             −14.376   −53.936    25.184    .159   .025   .459
  Granulocytes number (×10^9^/L)                     36             2.044     −8.389     12.476    .086   .007   .688
  Platelets (×10^9^/L)                               36             −0.167    −0.981     0.647     .095   .009   .674

*Note.* B = slope; BMI = body mass index; FBG = fasting blood glucose; HDL-C = high-density lipoprotein cholesterol; LCI = lower 95% confidence interval; UCI= upper 95% confidence interval; LDL-C = low-density lipoprotein cholesterol; MCH = mean cell hemoglobin; MCHC = mean cell hemoglobin concentration; MCV = mean cell volume; *N* = sample size; PCV = packed cell volume; *R* = Pearson linear correlation coefficient; *R^2^* = determinant coefficient; RBC = red blood cell; TG = triglycerides; WBC = white blood cell.

###### 

The Univariate Association Between Factors and Salivary Testosterone in Non-Sleep-Deprived Group Using Simple Liner Regression.

![](10.1177_1557988317735412-table3)

  Univariate effects estimates                       Coefficients                                               
  -------------------------------------------------- -------------- --------- --------- --------- ------ ------ ------
  Serum serotonin (ng/mL)                            41             0.178     −0.294    0.651     .123   .015   .450
  Salivary morning cortisol (nmol/L)                 41             10.008    −2.269    22.285    .273   .075   .107
  Salivary night cortisol (nmol/L)                   41             19.614    −9.913    49.141    .245   .060   .185
  Salivary morning dehydroepiandrosterone (nmol/L)   41             35.726    −38.076   109.528   .166   .028   .332
  Salivary night dehydroepiandrosterone (nmol/L)     41             −0.016    −0.128    0.096     .053   .003   .777
  FBG (mg/dL)                                        41             1.874     −3.523    7.271     .112   .012   .487
  Leptin (ng/mL)                                     41             −.822     −4.834    3.191     .066   .004   .681
  Vitamin B12 (pg/mL)                                41             0.015     −0.355    0.385     .013   .000   .936
  Folic acid (ng/mL)                                 41             −6.533    −20.008   6.942     .159   .025   .332
  TG (mg/dL)                                         41             0.413     −0.322    1.148     .192   .037   .261
  Total cholesterol (mg/dL)                          41             0.076     −1.485    1.637     .017   .000   .921
  HDL-C (mg/dL)                                      41             −0.305    −6.335    5.724     .018   .000   .919
  LDL-C (mg/dL)                                      41             0.122     −1.565    1.809     .025   .001   .884
  BMI (kg/m^2^)                                      41             −13.473   −63.791   −63.791   .086   .007   .591
  Body weight (kg)                                   41             −0.969    −3.775    1.836     .118   .014   .488
  Height (cm)                                        41             −4.531    −10.929   1.867     .236   .056   .159
  WBC (10^9^/L)                                      41             −18.782   −44.761   7.196     .241   .058   .151
  RBC (×10^12^/L)                                    41             13.712    −53.757   81.181    .071   .005   .682
  Hemoglobin (g/dL)                                  41             −1.046    −30.277   28.186    .012   .000   .943
  PCV (%)                                            41             −0.164    −7.941    7.612     .007   .000   .966
  MCV (fL)                                           41             1.856     −8.159    11.870    .060   .004   .710
  MCH (pg)                                           41             0.595     −20.069   21.259    .010   .000   .954
  MCHC (g/dL)                                        41             −4.872    −27.788   18.044    .074   .005   .668
  Lymphocytes number (×10^9^/L)                      41             1.031     −4.558    6.621     .066   .004   .710
  Monocytes (%)                                      41             9.514     −12.045   31.072    .162   .026   .375
  Granulocytes number (×10^9^/L)                     41             −0.310    −5.105    4.485     .024   .001   .896
  Platelets (×10^9^/L)                               41             −0.022    −0.852    0.808     .010   .000   .957

*Note.* B = slope; BMI = body mass index; FBG = fasting blood glucose; HDL-C = high-density lipoprotein cholesterol; LCI = lower 95% confidence interval; UCI = upper 95% confidence interval; LDL-C = low-density lipoprotein cholesterol; MCH = mean cell hemoglobin; MCHC = mean cell hemoglobin concentration; MCV = mean cell volume; *N* = sample size; PCV = packed cell volume; *R* = Pearson linear correlation coefficient; *R^2^* = determinant coefficient; RBC = red blood cell; sT = salivary testosterone, TG = triglycerides; WBC = white blood cell.

###### 

The Multivariate Association Between Factors and Salivary Testosterone in Sleep-Deprived Group by Using Multiple Liner Regression (Stepwise Method).

![](10.1177_1557988317735412-table4)

  Univariate effects estimates   Coefficients                                             
  ------------------------------ -------------- -------- -------- --------- ------ ------ -------
  HDL-C (mg/dL)                  36             14.356   9.944    18.769    .773   .597   .009
  BMI (kg/m^2^)                  36             78.767   43.316   114.219   .896   .802   .003
  Serum serotonin (ng/mL)        36             0.730    0.334    1.126     .977   .955   \<.00

*Note.* LCI = lower 95% confidence interval; UCI = upper 95% confidence interval; *N* = sample size; B = slope; *R* = Pearson linear correlation coefficient; *R^2^* = determinant coefficient.

Correlations of sT in SD Group {#section13-1557988317735412}
------------------------------

[Table 2](#table2-1557988317735412){ref-type="table"} presents sT correlation coefficients for three selected variables in the SD study group. The multiple linear correlation model of HDL-C, BMI, and serum serotonin is significantly and positively correlated with sT (*r* = .977, *p* \< .05). No correlations were reported between HDL-C, BMI, serum serotonin, and sT in the NSD group.

Stepwise Regression Analysis {#section14-1557988317735412}
----------------------------

Stepwise regression analysis was performed to investigate which IDVs accounted for these associations with sT changes. In the SD study group, the multiple linear regression model of HDL-C, BMI, and serum serotonin was significantly influenced by sT (*R²* = .955, *p* \< .05). These predictors together explained approximately 96% of the variance in sT levels in the SD study group. No predictive variables for sT were identified in the NSD group ([Table 3](#table3-1557988317735412){ref-type="table"}).

Discussion {#section15-1557988317735412}
==========

Most of the studies on the association of salivary or serum T with sleep deprivation were conducted on the elderly ([@bibr2-1557988317735412]; [@bibr6-1557988317735412]; [@bibr31-1557988317735412]). Few reports are available so far on sT in healthy young or adolescent males ([@bibr13-1557988317735412]; [@bibr15-1557988317735412]). The current results reported an increase of sT in SD men compared with an NSD group. In addition, elevated sT in SD participants was significantly positively correlated with HDL-C, BMI, and serum serotonin levels. The effects of T on lipid profile, particularly for HDL-C, are modest and variable ([@bibr8-1557988317735412]; [@bibr10-1557988317735412]; [@bibr42-1557988317735412]). An inverse association was observed between serum lipid profile and T levels except for HDL-C ([@bibr11-1557988317735412]; [@bibr42-1557988317735412]). The latter association was positive when adjusted for adiposity. Nevertheless, HDL-C was no longer significant ([@bibr8-1557988317735412]). [@bibr37-1557988317735412] have noted a positive correlation between obesity-associated markers and age with elevated lipid profile parameters, except for HDL-C. This is consistent with recent studies, which have reported that low T is associated with accelerated atherosclerosis ([@bibr24-1557988317735412]).

Further, one quarter of men with coronary artery disease (CAD) were biochemically hypogonadal according to a previous study by [@bibr24-1557988317735412]. Accordingly, a preventive potential of T during the progressive mechanisms of CVD was acknowledged ([@bibr58-1557988317735412]). The variations of T predictors such as LDL and HDL in previous associated studies were mostly age dependent ([@bibr19-1557988317735412]; [@bibr27-1557988317735412]; [@bibr40-1557988317735412]). In this context, the current findings can be considered as evident during young age. Inconsistent results were identified due to therapy with high doses of T ([@bibr42-1557988317735412]) or due to the fact that they were case studies ([@bibr29-1557988317735412]).

It is well known that T is one of the anabolic hormones that mediates regulation of skeletal muscle protein balance ([@bibr49-1557988317735412]) and increases muscle mass ([@bibr27-1557988317735412]). A particular problem with BMI, as an index of obesity, is that it does not differentiate between body lean mass and body fat mass, whereby a person can have a high BMI but still have a very low fat mass and vice versa ([@bibr35-1557988317735412]; [@bibr44-1557988317735412]). For instance, [@bibr28-1557988317735412] considered that BMI is a reliable predictor of subcutaneous fat thickness. To evaluate this dilemma, serum levels of leptin were compared as an obesity predictor. Serum leptin levels were higher in the NSD group in comparison to the SD group. Comparable results in previous studies have reported a significant decrease in total T serum levels in obese young men compared to men with normal BMI ([@bibr30-1557988317735412]).

[@bibr19-1557988317735412] demonstrated similar T effects on muscle mass in aging men. These findings confirmed anabolic effects of T on muscle mass rather than obesity.

On the other hand, a few previous studies have mentioned that sleep deprivation was negatively associated with serum serotonin in older people ([@bibr48-1557988317735412]). In young men, the results were ambiguous. Partial similarity with this study's results about the association of elevated T with serum serotonin in the SD group was observed in animal models. Although elevated serum serotonin levels were noted in sleep deprivation--induced rats ([@bibr57-1557988317735412]), luteinizing hormone (LH) secretion was inhibited. [@bibr36-1557988317735412] reported that sleep deprivation increased extracellular serotonin in the rat hippocampus. These findings suggested that decreased serum levels in SD rats may be mediated by a 5-HT-related mechanism ([@bibr56-1557988317735412]).

To our knowledge, there are no clinical reports supporting this potential mechanism. [@bibr10-1557988317735412] and [@bibr21-1557988317735412] concluded that men with low T are at greater risk of depression or cognitive impairment functions ([@bibr22-1557988317735412]). This study's results indirectly confirmed these findings, where the association between sT and serum serotonin was positive in SD young men. These two factors could be independent of each other. However, decline of serum serotonin and T with advanced age ([@bibr54-1557988317735412]) are well known as early predictors for depression and CVD.

Finally, there are some limitations to this study, which can be summarized in the following three points. First, the sT sample size (= number of measurements in a sample) was performed only once due to limited funding. Second, only sleep duration was obtained and no other questions detailing sleep quality were raised. Third, there was a lack of data collection of time interval between participants' waking up and sampling. However, throughout the entire study period, the authors made the necessary arrangements for participants to be present for sampling at 7 a.m.

Taken together, these observations conclude that positive correlations of sT with HDL-C and serum serotonin predict significant physiological adaptation to sleep deprivation in young men.
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